Notes / Company

Caplin Point Laboratories Ltd.

CAPLIPOINT BSE 524742 ISIN INE475E01026 Pharmaceuticals

Fundamentals

Market cap: ₹19,109 cr
P/E: 29.80×
ROE: 18.81%
Debt / equity: 0.00
Div yield: 0.16%
52-week range: 1502.45 — 2587.00

Research on Tijori Finance

Company snapshot

Caplin Point Laboratories Ltd.

Pharmaceuticals

₹15,389 cr

P/E 24.00×

Latest quarter · Mar 2026

Sales₹600 cr

Net profit₹173 cr

Op. margin+34.0%

EPS₹22.38

Strength & growth

Debt / equity0.00×

Current ratio6.97×

Sales CAGR+21.6%

EPS CAGR+27.6%

The timeline — 1 note on Caplin Point Laboratories Ltd.

May 2026

21 May 26 · 6:22 PM IST Brief

Brief · Earnings · Mid cap

Caplin Point posts its Q4 FY26 earnings call transcript.

A routine regulatory filing of a completed event. The transcript adds nothing beyond the live call on May 14.

Verify on exchange BSE filings for CAPLIPOINT NSE filings for CAPLIPOINT Tijori Finance company page